Introduction
The Oct-4 POU transcription factor is expressed in mouse totipotent embryonic stem and germ cells. The expression of human Oct-4 is comparable with the pattern in the mouse, suggesting that it may have a similar function in preventing human totipotent embryo cells from differentiating. Each type of established mammalian pluripotent stem cell lineÐembry-onal carcinoma (EC) cells, embryonic stem (ES) cells and embryonic germ (EG) cellsÐexpress Oct-4, which disappears rapidly when the cells differentiate. Accordingly, Oct-4 is considered to be a marker of pluripotent stem cells (Donovan, 2001; Pesce and Scho Èler, 2001) .
Human amniotic¯uid cells are used for routine prenatal genetic diagnosis of a wide range of fetal abnormalities caused by genetic alterations. Although this routine diagnosis is well established, little is known about the origin and properties of these cells. Cells of different embryonic/fetal origins of all three germ layers have been reported to exist in amniotic¯uid, and for speci®c subsets of amniotic¯uid cells the origins still need to be clari®ed (Milunsky, 1979; Hoehn and Salk, 1982; Gosden, 1983; Prusa and Hengstschla Èger, 2002) .
The purpose of this study was to investigate whether human amniotic¯uid contains cells expressing the transcription factor Oct-4.
Materials and methods

Amniotic¯uid cells
Amniotic¯uid cell samples were obtained from amniocentesis all performed after the 14th week of pregnancy for routine prenatal diagnosis. The indications were advanced maternal age and the cytogenetic analyses revealed normal karyotypes. This project has been reviewed and accepted by the ethics commission of the University of Vienna, Austria (project number: 036/2002) and each patient signed a written informed consent. RT±PCR RNA of amniotic¯uid cells was prepared using TriReagent (Molecular Research Center, Inc., Cincinnati, OH, USA). First-strand cDNA synthesis and PCR were performed using the rp-RT Mix (ViennaLab, Austria) following the protocol provided by the manufacturer. Sequences and PCR conditions have been described previously for the ®rst used Oct-4-speci®c oligonucleotide set (Monk and Holding, 2001; in Figure 1 designated`primer set 1') and for the second set (Xu et al., 2001; in Figure 1 designated`primer set 2'). The oligonucleotides speci®c for stem cell factor have been designed and synthesized by VBC Genomics (Vienna, Austria) according to the sequence published by Martin et al. (1990) , and the PCR conditions were the same. For the analysis of vimentin mRNA expression, speci®c oligonucleotides and PCR conditions were chosen according to Shamblott et al. (2001) . For the analysis of alkaline phosphatase mRNA, speci®c oligonucleotides and PCR conditions were chosen according to Pittenger et al. (1999) . As an internal standard, the expression of 18S rRNA was analysed.
Western blot analyses
For Western blot analyses, protein extracts were prepared in buffer containing 20 mmol/l HEPES pH 7.9, 0.4 mol/l NaCl, 2.5% glycerol, 1 mmol/l EDTA, 1 mmol/l phenylmethylsulfonyl¯uoride, 0.5 mmol/l NaF, 0.5 mmol/l Na 3 VO 4 , 0.02 mg/ml leupeptin, 0.02 mg/ml aprotinin, 0.003 mg/ml benzamidine chloride, 0.1 mg/ml trypsin inhibitor and 0.5 mmol/l dithiothreitol (DTT). Cells were lysed by freezing and thawing, the extracts were centrifuged and the supernatants were stored at ±70°C. Protein concentrations were determined using the Bio-Rad protein assay reagent with bovine serum albumin as the standard. Proteins were run on an SDS±polyacrylamide gel and transferred to nitrocellulose. Blots were stained with Ponceau-S to visualize equal amounts of loaded protein (for the method see also Kubista et al., 2002) . For immunodetection, the anti-Oct-4 antibody C-10 (Santa Cruz, CA, USA) was used. As suggested by the manufacturer of the antibody, the rodent teratocarcinoma cell line F9 has been analysed as an Oct-4-positive control.
Immunocytochemistry
For immunocytochemical analyses of cellular Oct-4 expression, cells were ®xed in cold methanol/acetone (1:1) and incubated with antiOct-4 antibody C-10 (Santa Cruz) overnight at 4°C. Thereafter, cells were washed, incubated with a biotinylated secondary antibody (B7401, Sigma), washed again, and incubated with ExtrAvidin-Cy3 conjugate (red) (E4142, Sigma). For double staining, a second incubation with the cyclin A-speci®c antibody H-432 (Santa Cruz) was performed. This antibody was detected directly with a¯uorescein isothiocyanate (FITC)-conjugated anti-rabbit antibody (green) (F9887, Sigma). Cell nuclei were counterstained with 4¢,6-diamidino-2-phenylindole (DAPI; blue).
Results
RT±PCR was performed with 11 independent amniocentesis samples. In ®ve samples, Oct-4 mRNA expression was detectable. In Figure 1 representative samples are presented. To obtain more information regarding the nature of these cells and their potential, we investigated stem cell factor, vimentin and alkaline phosphatase mRNA expression. All three of these molecules are markers for pluripotent stem cells (for a detailed description of such markers see http://www.nih.gov/news/ stemcell/scireport.htm). Stem cell factor (Martin et al., 1990 ) is known to be expressed in ES cells, EC cells, haematopoietic stem cells and mesenchymal stem cells. Vimentin is known to be expressed in ectodermal, neural and pancreatic progenitor cells (compare also Shamblott et al., 2001) . Alkaline phosphatase (compare Pittenger et al., 1999) expression can be found in ES cells and in EC cells. By analysing six independent amniotic¯uid cell samples, we found that all the three Oct-4-positive samples also expressed these three markers, whereas the three Oct-4-negative cell samples did not (Figure 1) .
Western blot analyses demonstrated Oct-4 protein expression in samples with positive RT±PCR results (Figure 2 ). Immunocytochemical analyses of positive samples revealed that~0.1±0.5% of amniotic¯uid cells expressed Oct-4 protein (Figures 3 and 4) . The low number of Oct-4-expressing cells can be assumed to be the explanation for the low expression levels in the amniotic¯uid samples detected by Western blot analyses (Figure 2 ). In agreement with the known localization of this POU transcription factor (Pesce and Scho Èler, 2001 ), Oct-4 signals were detected in the nucleus (Figures 3 and 4) .
To investigate further the question of whether the Oct-4-positive amniotic¯uid cells are actively dividing, we performed double immunostaining experiments with anti-cyclin A antibody. The cell cycle regulator cyclin A is only expressed in proliferating cells (for a review see Hengstschla Èger et al., 1999). Our ®nding that cyclin A protein is expressed in Oct-4-positive amniotic¯uid cells demonstrates that these cells proliferate (Figure 4) .
Discussion
A major aim in stem cell research is the identi®cation of new sources of stem cells with as yet unknown properties. There is no doubt as to the importance of Oct-4 for the maintenance of stem cells. Each established mammalian pluripotent stem cell line expresses Oct-4, which rapidly disappears when the cells differentiate (Pesce and Scho Èler, 2001) .``If you wanted a marker of pluripotent stem cells, you wouldn't go far wrong if you picked the POU-domain transcription factor, Oct-4.'' (Donovan, 2001) . Accordingly, we have analysed human amniotic¯uid cell samples for the expression of this marker. For RT±PCR detection of Oct-4 mRNA, two independent sets of oligonucleotides have been used, which previously were shown to be speci®c for the human sequence of this transcription factor (Monk and Holding, 2001; Xu et al., 2001 ). In the RT±PCR-positive samples, we detected the Oct-4 protein of the correct size using a speci®c antibody in Western blot analyses. To check further whether the amniotic¯uid cells exhibit the correct intracellular localization of this transcription factor, we performed immunocytochemical investigations. The observed nuclear localization again con®rms that the expression of the correct molecule has been analysed in our study. In addition, this ®nding furthers suggest that Oct-4 expressed in amniotic¯uid cells is functional.
The immunocytochemical analyses were also of importance in answering the question of exactly how many cells within one positive amniotic¯uid cell sample express Oct-4. It has been reported previously that some adult human tissues express low levels of Oct-4 as analysed by RT±PCR. Whether Oct-4 protein expression is detectable in these tissues remained elusive (Takeda et al., 1992) . In Western blot analyses, we found that speci®c human tissues samples, others than amniotic¯uid cells, were positive for Oct-4 expression in RT±PCR but did not express Oct-4 protein (data not shown). This ®nding provides evidence for post-transcriptional control of Oct-4 expression in speci®c human cells. In the study presented here, we observed that a subpopulation within amniotic¯uid cell samples can be found to be Oct-4 positive. The fact that onlỹ 0.1±0.5% of the cells within such a positive sample express this transcription factor, together with the ®nding that only about half of the analysed amniotic¯uid samples contained Oct-4-positive cells, suggests that (i) the Oct-4-positive signals are speci®c for a distinct subpopulation within an amniotic uid cell sample and are not due to a low background of Oct-4 expression in all different cell types existing in such a sample; and (ii) Oct-4-positive cells cannot be detected in every analysed sample. The reasons for this observation still need to be clari®ed.
When ES cells are triggered to differentiate, Oct-4 is downregulated. Loss of Oct-4 expression at the blastocyst stage causes the cells of the inner cell mass to differentiate into trophoectoderm cells (Pesce and Scho Èler, 2001 ). Experiments in mouse models indicate that an Oct-4 expression level of 50±150% of the endogenous amount in ES cells is permissive for self-renewal and maintenance of totipotency. Up-regulation above these levels causes stem cells to express genes involved in the lineage differentiation of primitive endoderm (Niwa et al., 2000) . At present, this model has not been proven in humans. However, it could be considered of interest to compare the level of expression of Oct-4-positive amniotic uid cells with that in different stem cell types and lines to obtain further insights into what type of stem cells are detected in amniotic¯uid cell samples. Experiments with human ES cells or stem cell lines are forbidden in Austria.
To obtain further information about amniotic¯uid cells in connection with stem cell research, we sought to answer two important questions. (i) Can other markers, known to be expressed in pluripotent human stem cells, be found in amniotic¯uid samples? (ii) Are the Oct-4-positive amniotic uid cells actively dividing? RT±PCR analyses revealed that in amniotic¯uid cell samples containing Oct-4 positive cells, the mRNAs of three genes, known to be expressed in pluripotent human stem cells, can be detected: stem cell factor, vimentin and alkaline phosphatase. Double staining experiments further demonstrated that Oct-4-positive amniotic¯uid cells can actively divide, which was proven by the detection of cyclin A expression. However, ®nal proof for a putative pluripotency of such Oct-4-positive amniotic¯uid cells would include experiments to isolate them and to differentiate them into different lineages. Such experiments are planned in our laboratory. We believe this new source of human stem cells to be interesting, even if these cells could be proven to harbour the potency to differentiate only in a speci®c subset of lineages. In this respect, it will also be of interest to try to elucidate the origin of the Oct-4-positive cells in the human amniotic¯uid. There exist a lot of different possibilities, including, for example, aberrantly migrating primordial germ cells.
Another important marker for human pluripotent stem cells is telomerase activity (for a detailed description of such markers see http://www.nih.gov/news/stemcell/scireport.htm). All ES cell lines express high levels of telomerase, the enzyme that helps to maintain telomeres which protect the ends of chromosomes. Telomerase activity and long telomeres are characteristic of proliferating cells in embryonic tissues and of germ cells. Human non-transformed somatic cells, however, do not show telomerase activity and their telomeres are considerably shorter (Amit et al., 2000) . Interestingly, telomerase activity can be detected in human amniotic¯uid cell samples (Mosquera et al., 1999) . This observation is in agreement with the assumption that such samples can contain stem cells of high potency, as suggested by our data.
We believe the ®ndings reported here, together with the recent demonstration of the successful usage of amniotic¯uid cells for tissue engineering approaches (Kaviani et al., 2001) , to be encouraging for the further investigation of human amniotic¯uid as a putative new source of stem cells with high potency. 
